CN107955041B - Iridium complex with dual-emission property and preparation method and application thereof - Google Patents

Iridium complex with dual-emission property and preparation method and application thereof Download PDF

Info

Publication number
CN107955041B
CN107955041B CN201710977794.0A CN201710977794A CN107955041B CN 107955041 B CN107955041 B CN 107955041B CN 201710977794 A CN201710977794 A CN 201710977794A CN 107955041 B CN107955041 B CN 107955041B
Authority
CN
China
Prior art keywords
iridium complex
dual
complex
iridium
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710977794.0A
Other languages
Chinese (zh)
Other versions
CN107955041A (en
Inventor
许文娟
翟伟俊
黄维
赵强
刘淑娟
陈键
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Posts and Telecommunications
Original Assignee
Nanjing University of Posts and Telecommunications
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Posts and Telecommunications filed Critical Nanjing University of Posts and Telecommunications
Priority to CN201710977794.0A priority Critical patent/CN107955041B/en
Publication of CN107955041A publication Critical patent/CN107955041A/en
Application granted granted Critical
Publication of CN107955041B publication Critical patent/CN107955041B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0033Iridium compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)

Abstract

The invention provides an iridium complex with dual-emission property, a preparation method and application thereof, wherein the iridium complex has a structural formula shown as the following formula:
Figure DDA0001436395410000011
the complex consists of a metal iridium center, a neutral N ^ N auxiliary ligand and two ring metal C ^ N ligands, and the C ^ N ligands contain 4-aminophenyl ether groups. The ionic iridium complex has obvious dual-emission property. In addition, after the carbon-oxygen bond in the ligand is reacted with hypochlorite ions, the carbon-oxygen bond is broken, so that the excited state and the photophysical properties of the iridium complex are changed, and the detection of the hypochlorite ions is realized. The phosphorescent iridium complex material has important application prospect in the biological aspect.

Description

Iridium complex with dual-emission property and preparation method and application thereof
Technical Field
The invention belongs to the technical field of organic photoelectric functional materials, and particularly relates to an iridium complex with dual-emission property, a preparation method thereof and application thereof in hypochlorite detection.
Background
Hypochlorite ion (ClO)-) Is an important active oxygen and an important intermediate product in various biological life activities. Endogenous hypochlorous acid is mainly produced in granulocytes (macrophages, monocytes, neutrophils, etc.) and is generated by the reaction of chloride ions and hydrogen peroxide catalyzed by myeloperoxidase. Hypochlorous acid has the function of a bactericide in the body and plays an important role in the immune system. However, hypochlorous acid is harmful to the human body when insufficient or excessive. Therefore, it is important to be able to detect hypochlorous acid in a biological sample quickly, sensitively and accurately.
Luminescence imaging technology using fluorescence chemosensing provides a unique method of visualizing inter-HOCl systems. The fluorescence sensing imaging technology is considered as a unique method for detecting hypochlorous acid due to high sensitivity, good selectivity, simple data acquisition and high spatial resolution and time resolution. In recent years, some hypochlorous acid fluorescent probes have been synthesized for monitoring hypochlorous acid production in living cells. Weiying Lin synthesizes a method for detecting ClO-When used for an analyte, the fluorescence emission ratio (I509/I439) can be increased from 0.28 to 2.74 with higher selectivity (chem. Eur. J.,2009,15, 2305-2309). The probe is based on the detection of a fluorescent signal. Phosphorescent signal detection has the following advantages compared to fluorescent signals: the quantum well quantum. Therefore, the phosphorescent Ir (III) complex has important application in phosphorescent biosensing and bioimaging. The complex with dual-emission property used for ion detection has the advantages, and can realize ratio detection, so that the signal-to-noise ratio of detection can be further improved; when the method is applied to cell imaging, ratio imaging and detection of target objects in cells can be realized.
The invention provides an iridium complex with dual-emission property and a preparation method thereof, and provides application of the complex in detecting hypochlorite ions and in cell imaging.
The invention is supported by the national science fund project (No.21671109) and the Jiangsu science fund surface project (No. BK 20141422).
Disclosure of Invention
The technical problem is as follows: the invention aims to provide an iridium complex with dual-emission property and a preparation method thereof, and provides application of the complex in detecting hypochlorite ions and in cell imaging.
The technical scheme is as follows: an iridium complex with dual-emission property has a structural formula shown as the following formula:
Figure BDA0001436395390000021
wherein, N ^ N ligand
Figure BDA0001436395390000022
One of the following five heterocyclic compounds:
Figure BDA0001436395390000023
the preparation method of the iridium complex with dual-emission property comprises the following steps:
Figure BDA0001436395390000024
wherein, N ^ N ligand
Figure BDA0001436395390000031
One of the following five heterocyclic compounds:
Figure BDA0001436395390000032
preferably, in the step of preparing the compound 6 from the compound 5, the reaction solvent is a mixed solution of 2-ethoxyethanol and water, and the reaction conditions are 110 ℃ and 24 hours.
The iridium complex with dual-emission property is applied to hypochlorite detection.
The iridium complex with dual-emission property is applied to ratiometric fluorescent probes.
The use of the above iridium complexes with dual emission properties in ratio imaging.
Has the advantages that:
the iridium complex has an obvious dual-emission phenomenon. The carbon-oxygen bond in the iridium complex reacts with hypochlorite ions to break the carbon-oxygen bond, so that photophysical properties of the iridium complex are changed, the hypochlorite ions can be detected, and the method is used for detecting the ratio of the intracellular hypochlorite ions.
Drawings
FIG. 1 shows preparation of the complex Ir2 from example 11H NMR spectrum;
FIG. 2 is a mass spectrum of complex Ir2 of example 1.
FIG. 3 is a mass spectrum of complex Ir2 of example 1 after addition of excess hypochlorite ion.
FIG. 4 shows the double emission of the complex Ir2 from example 1 in different solvents.
Detailed Description
The technical scheme of the invention is further explained by combining the attached drawings.
The iridium complex has the following structural general formula:
Figure BDA0001436395390000041
wherein, N ^ N ligand
Figure BDA0001436395390000042
One of the following five heterocyclic compounds:
Figure BDA0001436395390000043
the iridium complex consists of a metal iridium center, a neutral N ^ N auxiliary ligand and two ring metal C ^ N ligands, and the C ^ N ligands contain 4-aminophenyl ether groups.
In order to better understand the contents of the present patent, the following further illustrates the technical solution of the present invention by specific examples. The method specifically comprises synthesis, property determination, titration experiment, cell imaging and the like. These examples do not limit the invention.
Example 1
When the N ^ N ligand is
Figure BDA0001436395390000051
The specific steps of preparing the iridium complex Ir2The following were used:
Figure BDA0001436395390000052
synthesis of Compound a: first, 2-aminobenzenethiol (4g, 32mmol), p-hydroxybenzaldehyde (4.12mL) were added to a 250mL two-necked flask, and vacuum-charged with nitrogen-evacuated on the double drain, and the cycle was repeated three times. Next, redistilled N, N-dimethylformamide (5mL) was injected into the reaction system, and the reaction system was protected with nitrogen. Finally, the temperature of the reaction system is raised to 110 ℃, and the reaction is stirred for 72 hours. After the reaction was complete, the solvent was removed under reduced pressure and recrystallized from ethanol to give a grey solid, compound a. Yield: 41.8 percent.
1H NMR(400MHz,d6-DMSO):δ=10.21(s,1H),8.07(d,J=7.9Hz,1H),8.00–7.87(m,3H),7.53–7.45(m,1H),7.43–7.33(m,1H),6.97–6.88(m,2H).
Synthesis of Compound b: adding the compound a (1.358g, 5mmol), p-fluoronitrobenzene (846mg, 6mmol) and potassium carbonate (1.382g, 10mmol) into a double-neck flask, vacuumizing on a double-row pipe, filling nitrogen and vacuumizing for three times, and finally protecting the reaction system by using nitrogen. Then, redistilled N, N-dimethylformamide (5mL) was injected into the reaction system, and the temperature of the reaction system was raised to 70 ℃ to react for 24 hours. After the reaction is completed, extracting with water and ethyl acetate, removing the solvent by rotary removal under reduced pressure, and purifying with a silica gel column to obtain a compound b. Yield: 52.7 percent.
1H NMR(400MHz,CDCl3):δ=8.28–8.23(m,2H),8.16(d,J=8.8Hz,2H),8.08(d,J=8.2Hz,1H),7.93(d,J=8.0Hz,1H),7.52(t,J=7.6Hz,1H),7.42(t,J=8.0Hz,1H),7.21(d,J =8.8Hz,2H),7.12(d,J=9.3Hz,2H).
Synthesis of dichloro bridge c: compound b (348mg, 1mmol), iridium trichloride hydrate (176mg, 0.5mmol) were charged into a two-necked flask, magnetons were added, a condenser tube was sealed, vacuum was applied 3 times with nitrogen, and the solvents 2-ethoxyethanol (9mL) and water (3mL) were injected by syringe and reacted at 110 ℃ for 24 hours. After the reaction is completed, cooling the reaction system to room temperature, adding a proper amount of water and ethanol (2:1), standing the reaction solution for a moment, separating out a large amount of solids, filtering the reaction solution in a suction manner, and drying the reaction solution for later use, wherein the solids are the dichloro-bridge c.
Synthesis of iridium complex Ir 1: taking dichloro-bridge c (184mg, 0.1mmol) and auxiliary ligand 2,2' -bipyridine (31mg, 0.2mmol), putting into a double-neck flask, adding magnetons, packaging a condenser tube, vacuumizing and filling nitrogen for 3 times, injecting a proper amount of dichloromethane and methanol (volume ratio of 3:1) by using an injector, raising the temperature of a reaction system to 40 ℃, and reacting for 10 hours. And (3) taking a small amount of reaction liquid by using a long needle to monitor the reaction progress, adjusting the temperature to 25 ℃ when the raw materials almost completely react, adding excessive potassium hexafluorophosphate, and continuously stirring the reaction liquid for 4 hours. And (3) cooling the reaction solution, extracting the reaction solution for 3 times by using a small amount of dichloromethane and a large amount of water, taking a dichloromethane layer as a product layer, spin-drying, and purifying by column chromatography. The yellow solid product is the complex Ir 1.
1H NMR(400MHz,d6-DMSO):δ=8.82(d,J=8.3Hz,2H),8.31(t,J=7.8Hz,2H),8.10(d,J=4.8,2H),8.07(d,J=8.4,2H),8.03–7.93(m,6H),7.84–7.78(m,2H),7.24(t,J=7.7Hz,2H),7.10(t,J=7.0Hz,2H),7.08–7.03(m,4H),6.94(dd,J=8.5,2.4Hz,2H),5.94(d,J= 8.4Hz,2H),5.59(d,J=2.4Hz,2H)。
Theoretical MS value: 1043.13, MS (MALDI-TOF) [ m/z ] 1042.031.
Synthesis of iridium complex Ir 2: 104mg of iridium complex Ir1 and 20mg of palladium on carbon are placed in a two-necked flask, evacuated 2 times, added with ethanol and evacuated once more. Hydrazine hydrate was added and the reaction was carried out at 80 ℃ for 15 h. And (4) detecting the reaction by mass spectrometry. And settling the n-hexane and the dichloromethane for 3 times to obtain a light yellow solid of 40mg, namely the iridium complex Ir 2.
FIG. 1 shows a hydrogen spectrum of the iridium complex Ir2 obtained with MeOD as solvent. As can be seen from FIG. 1, the synthesized complex is designed by the present invention.
1H NMR(400MHz,MeOD):δ=8.60(d,J=8.0Hz,2H),8.17-8.11(m,4H),7.88(d,J=8.1 Hz,2H),7.73(d,J=8.5Hz,2H),7.65–7.59(m,2H),7.27(t,J=7.5Hz,2H),6.96(t,J=7.8Hz, 2H),6.67(dd,J=8.5,2.3Hz,2H),6.46-6.22(m,8H),5.98(d,J=8.5Hz,2H),5.47(d,J=2.3 Hz,2H)。
Theoretical MS value: 983.18, MS (MALDI-TOF) [ m/z ] 982.197.
Mass spectrometric testing of iridium complexes Ir 2:
the mass spectra of the iridium complex Ir2 and its added excess sodium hypochlorite were tested separately and the results are shown in FIGS. 2 and 3.
The results show that the molecular ion peak 982.197 of the mass spectrum is equal to the theoretical value 983.18(Ir 2-PF)6) The consistency is achieved; the molecular ion peak after adding excessive sodium hypochlorite into Ir2 is 799.163, which is consistent with the molecular weight of the complex Ir2 for removing two aminophenyl ether groups, and the detection mechanism of hypochlorite ions can be determined as shown in the following formula:
Figure BDA0001436395390000071
emission spectra of iridium complex Ir2 in different solvents:
the iridium complex Ir2 solid is respectively added into the deoxygenated solvent, and the emission spectrum is respectively tested, and the result is shown in the attached figure 4. The results show that the double-emission phenomenon is obvious in toluene, chloroform and water.
Example 2: when the N ^ N ligand is
Figure BDA0001436395390000072
The preparation method of the iridium complex Ir4 comprises the following synthetic steps:
Figure BDA0001436395390000073
synthesis of Compound a: first, 2-aminobenzenethiol (4g, 32mmol), p-hydroxybenzaldehyde (4.12mL) was added to a 250mL two-necked flask, and vacuum-charged with nitrogen-evacuated on the double drain, and the cycle was repeated three times. Next, redistilled N, N-dimethylformamide (5mL) was injected into the reaction system, and the reaction system was protected with nitrogen. Finally, the temperature of the reaction system is raised to 110 ℃, and the reaction is stirred for 72 hours. After the reaction was complete, the solvent was removed under reduced pressure and recrystallized from ethanol to give a grey solid, compound a. Yield: 41.8 percent.
1H NMR(400MHz,d6-DMSO):δ=10.21(s,1H),8.07(d,J=7.9Hz,1H),8.00–7.87(m,3H),7.53–7.45(m,1H),7.43–7.33(m,1H),6.97–6.88(m,2H).
Synthesis of Compound b: adding the compound a (1.358g, 5mmol), p-fluoronitrobenzene (846mg, 6mmol) and potassium carbonate (1.382g, 10mmol) into a double-neck flask, vacuumizing on a double-row pipe, filling nitrogen and vacuumizing for three times, and finally protecting the reaction system by using nitrogen. Then, redistilled N, N-dimethylformamide (5mL) was injected into the reaction system, and the temperature of the reaction system was raised to 70 ℃ to react for 24 hours. After the reaction is completed, extracting with water and ethyl acetate, removing the solvent by rotary removal under reduced pressure, and purifying with a silica gel column to obtain a compound b. Yield: 52.7 percent.
1H NMR(400MHz,CDCl3):δ=8.28–8.23(m,2H),8.16(d,J=8.8Hz,2H),8.08(d,J=8.2Hz,1H),7.93(d,J=8.0Hz,1H),7.52(t,J=7.6Hz,1H),7.42(t,J=8.0Hz,1H),7.21(d,J =8.8Hz,2H),7.12(d,J=9.3Hz,2H).
Synthesis of dichloro bridge c: compound b (348mg, 1mmol), iridium trichloride hydrate (176mg, 0.5mmol) were charged into a two-necked flask, magnetons were added, a condenser tube was sealed, vacuum was applied 3 times with nitrogen, and the solvents 2-ethoxyethanol (9mL) and water (3mL) were injected by syringe and reacted at 110 ℃ for 24 hours. After the reaction is completed, cooling the reaction system to room temperature, adding a proper amount of water and ethanol (2:1), standing the reaction solution for a moment, separating out a large amount of solids, filtering the reaction solution in a suction manner, and drying the reaction solution for later use, wherein the solids are the dichloro-bridge c.
Synthesis of iridium complex Ir 3: taking dichloro-bridge c (184mg, 0.1mmol) and auxiliary ligand phenanthroline, putting the dichloro-bridge c and the auxiliary ligand phenanthroline into a double-neck flask, adding magnetons, packaging a condenser tube, vacuumizing and filling nitrogen for 3 times, injecting a proper amount of dichloromethane and methanol (volume ratio is 3:1) by using an injector, raising the temperature of a reaction system to 40 ℃, and reacting for 10 hours. And (3) taking a small amount of reaction liquid by using a long needle to monitor the reaction progress, adjusting the temperature to 25 ℃ when the raw materials almost completely react, adding excessive potassium hexafluorophosphate, and continuously stirring the reaction liquid for 4 hours. And (3) cooling the reaction solution, extracting the reaction solution for 3 times by using a small amount of dichloromethane and a large amount of water, taking a dichloromethane layer as a product layer, spin-drying, and purifying by column chromatography. Obtaining a yellow solid product, namely the iridium complex Ir 3.
1H NMR(400MHz,d6-DMSO):δ=8.62(d,J=8.3Hz,2H),8.01(t,J=7.8Hz,2H),8.07(d,J=8.4,2H),8.23–7.63(m,6H),7.82–7.58(m,2H),7.59(dd,J=6.0,0.7Hz,2H),7.22(t,J =7.7Hz,2H),7.20(t,J=7.0Hz,2H),7.08–7.03(m,4H),6.84(dd,J=8.5,2.4Hz,2H),5.84 (d,J=8.4Hz,2H),5.62(d,J=2.4Hz,2H)。
Synthesis of iridium complex Ir 4: putting the nitro complex 1 and palladium-carbon into a double-mouth bottle, vacuumizing for 2 times, adding ethanol, and vacuumizing once again. Hydrazine hydrate is added and the reaction is carried out for 15h at 80 ℃. And (4) detecting the reaction by mass spectrometry. And settling the normal hexane and the dichloromethane for 3 times to obtain a light yellow solid, namely the iridium complex Ir 4.
1H NMR(400MHz,MeOD):δ=8.62(d,J=8.0Hz,2H),8.27-8.31(m,4H),7.63(d,J=8.5 Hz,2H),7.34(dd,J=6.0,0.7Hz,2H),7.44–7.33(m,2H),7.27(t,J=7.5Hz,2H),7.01(t,J= 7.8Hz,2H),6.69(dd,J=8.5,2.3Hz,2H),6.36-6.22(m,8H),6.00(d,J=8.5Hz,2H),5.57(d, J=2.3Hz,2H)。
The iridium complex Ir4 and the mass spectrometry detection result of the iridium complex Ir4 added with excessive sodium hypochlorite are consistent with the result of example 1. Molecular ion peak 1006.97 and theoretical value 1006.18(Ir 4-PF) of iridium complex Ir4 mass spectrum6) The consistency is achieved; the molecular ion peak after the addition of excess sodium hypochlorite to Ir4 was 824.24, which is consistent with the ionic molecular weight of complex Ir4 for the removal of two aminophenyl ether groups. The iridium complex Ir4 may also be used for the detection of hypochlorite.
The iridium complex Ir4 has obvious dual-emission phenomenon in toluene, chloroform and water.

Claims (6)

1. An iridium complex having dual emission properties, characterized in that: the structural formula is shown as the following formula:
Figure FDA0001436395380000011
wherein, N ^ N ligand
Figure FDA0001436395380000012
One of the following five heterocyclic compounds:
Figure FDA0001436395380000013
2. the method for producing an iridium complex having a dual emission property as claimed in claim 1, wherein: the method comprises the following steps:
Figure FDA0001436395380000014
wherein, N ^ N ligand
Figure FDA0001436395380000021
One of the following five heterocyclic compounds:
Figure FDA0001436395380000022
3. the method for producing an iridium complex having a dual emission property as claimed in claim 2, wherein: in the step of preparing the compound 6 from the compound 5, the reaction solvent is a mixed solution of 2-ethoxyethanol and water, and the reaction conditions are 110 ℃ and 24 hours.
4. Use of the iridium complex with dual emission property according to claim 1 in hypochlorite detection.
5. Use of an iridium complex with dual emission properties according to claim 1 in ratiometric fluorescent probes.
6. Use of an iridium complex with dual emission properties according to claim 1 in ratio imaging.
CN201710977794.0A 2017-10-17 2017-10-17 Iridium complex with dual-emission property and preparation method and application thereof Active CN107955041B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710977794.0A CN107955041B (en) 2017-10-17 2017-10-17 Iridium complex with dual-emission property and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710977794.0A CN107955041B (en) 2017-10-17 2017-10-17 Iridium complex with dual-emission property and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN107955041A CN107955041A (en) 2018-04-24
CN107955041B true CN107955041B (en) 2020-03-31

Family

ID=61963950

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710977794.0A Active CN107955041B (en) 2017-10-17 2017-10-17 Iridium complex with dual-emission property and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN107955041B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102179944B1 (en) * 2019-03-19 2020-11-17 서울대학교 산학협력단 Electrochemiluminescent probe for detection of thiophenol
CN110437286B (en) * 2019-07-18 2021-09-03 常州大学 Synthesis and application of novel cyclometalated platinum complex dual-emission material

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103937487A (en) * 2014-03-25 2014-07-23 南京邮电大学 Phosphorescent fluorinion probe, preparation and applications thereof
CN106892947A (en) * 2017-02-28 2017-06-27 陕西师范大学 One kind contains(Hydrazinocarbonyl)Complex of iridium of ferrocene ligands and its preparation method and application

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103937487A (en) * 2014-03-25 2014-07-23 南京邮电大学 Phosphorescent fluorinion probe, preparation and applications thereof
CN106892947A (en) * 2017-02-28 2017-06-27 陕西师范大学 One kind contains(Hydrazinocarbonyl)Complex of iridium of ferrocene ligands and its preparation method and application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A naphthalene-based two-photon fluorescent probe for selective and sensitive detection of endogenous hypochlorous acid;Xiao-Hong Zhou et al.;《Talanta》;20160727;摘要,scheme 1 *

Also Published As

Publication number Publication date
CN107955041A (en) 2018-04-24

Similar Documents

Publication Publication Date Title
CN107793421B (en) Probe with aggregation-induced emission characteristic and preparation method and application thereof
US9862731B2 (en) Difluoroboron dipyrromethene fluorescent probe, production method and application thereof
Du et al. Highly selective fluorescent recognition of histidine by a crown ether–terpyridine–Zn (II) sensor
CN104357044B (en) A kind of fluorescent probe and its preparation method and application
Wu et al. Dansyl-based fluorescent chemosensors for selective responses of Cr (III)
CN104592983B (en) Fluorescent probes based on pyrene, and preparation method and application thereof
Huang et al. Structural modification of rhodamine-based sensors toward highly selective mercury detection in mixed organic/aqueous media
Liu et al. A fast-response, highly sensitive and selective fluorescent probe for the ratiometric imaging of hydrogen peroxide with a 100 nm red-shifted emission
Ma et al. A water-soluble tetraphenylethene based probe for luminescent carbon dioxide detection and its biological application
Li et al. A per-acetyl glycosyl rhodamine as a novel fluorescent ratiometric probe for mercury (II)
CN107602600B (en) Amino-substituted aza-BODIPY near-infrared pH fluorescent probe and preparation method and application thereof
CN107955041B (en) Iridium complex with dual-emission property and preparation method and application thereof
CN108658838B (en) Heptamethine indocyanine-based formaldehyde fluorescent probe and preparation method and use method thereof
CN109942508B (en) Ratio type carbon monoxide fluorescent probe and preparation method and application thereof
CN110526946B (en) Pyridine-bridged multiple-response receptor molecule and synthesis method and application thereof
CN101672780B (en) Analytical method for detecting trace mercury in aqueous medium based on the color change of fluorescence
CN112961671B (en) Fluorescent/phosphorescent light-emitting life polymer probe capable of simultaneously detecting multiple targets and application thereof
CN108048075B (en) Calcium ion fluorescent probe based on aggregation induction effect and preparation method and application thereof
CN110128430A (en) A kind of 8-hydroxyquinoline base click coughs up gallium complex pH fluorescence probe and preparation method thereof
CN103044406B (en) Coumarin derivatives and preparation method thereof and the application in detection cyanide ion
KR20110081697A (en) Compounds having al(iii) ion selectivity and chemosensor using the same
WO2014203067A1 (en) Electronically neutral metal complexes as biological labels
KR101583396B1 (en) Julolidine based compounds and agent for detecting zinc ion using the same
CN105606607B (en) A kind of preparation method and application than colour pattern mercury ion probe of the organic iridium of cationic (III) complex
CN110143985B (en) Iridium complex probe for identifying bisulfite and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant